Site US10030 — Jacksonville, Florida

Site US10030 is a clinical research site located in Jacksonville, Florida, United States 32224.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US10030 has participated in 2 clinical trials.

Therapeutic areas: Kidney Transplantation, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jacksonville

Browse all research sites in Florida · View every site in Jacksonville

• St. Luke's Hospital
• University of Florida-Jacksonville College of Medicine
• Rainbow Center at University of Florida Health
• University of Florida, Dept of Ophthalmology
• University of Florida /ID# 236876
• University of Florida Health Jacksonville, Shands Hospital
• University of Florida College of Medicine - Jacksonville Southside Women's Health
• Ascension St. Vincent's Riverside Hospital
• University of Florida Pediatric Weight Management Center
• University of Florida Health Sciences Center-Jacksonville
• The University of Florida Health System - UF Health Urology - Jacksonville
• University of Florida College of Med., Department of Ophthalmology, Jacksonville Health Science Cent

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10030?

Site US10030 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10030 conducted?

Site US10030 has 2 clinical trials on record. Their work covers Kidney Transplantation, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation.

Is Site US10030 accredited by Crixeo Clinical Trials?

Site US10030 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10030?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.